199 related articles for article (PubMed ID: 16093354)
1. Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding.
Zhu J; Balan V; Bronisz A; Balan K; Sun H; Leicht DT; Luo Z; Qin J; Avruch J; Tzivion G
Mol Biol Cell; 2005 Oct; 16(10):4733-44. PubMed ID: 16093354
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase.
Balan V; Leicht DT; Zhu J; Balan K; Kaplun A; Singh-Gupta V; Qin J; Ruan H; Comb MJ; Tzivion G
Mol Biol Cell; 2006 Mar; 17(3):1141-53. PubMed ID: 16407412
[TBL] [Abstract][Full Text] [Related]
3. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
4. Regulation and role of Raf-1/B-Raf heterodimerization.
Rushworth LK; Hindley AD; O'Neill E; Kolch W
Mol Cell Biol; 2006 Mar; 26(6):2262-72. PubMed ID: 16508002
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
Ikenoue T; Hikiba Y; Kanai F; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Aragaki J; Matsumura M; Kawabe T; Omata M
Cancer Res; 2003 Dec; 63(23):8132-7. PubMed ID: 14678966
[TBL] [Abstract][Full Text] [Related]
6. Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase.
Terai K; Matsuda M
EMBO Rep; 2005 Mar; 6(3):251-5. PubMed ID: 15711535
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of 338SSYY341 regulates specific interaction between Raf-1 and MEK1.
Xiang X; Zang M; Waelde CA; Wen R; Luo Z
J Biol Chem; 2002 Nov; 277(47):44996-5003. PubMed ID: 12244094
[TBL] [Abstract][Full Text] [Related]
8. PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway.
Coles LC; Shaw PE
Oncogene; 2002 Mar; 21(14):2236-44. PubMed ID: 11948406
[TBL] [Abstract][Full Text] [Related]
9. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.
Zhang BH; Guan KL
EMBO J; 2000 Oct; 19(20):5429-39. PubMed ID: 11032810
[TBL] [Abstract][Full Text] [Related]
10. MEK-1 activates C-Raf through a Ras-independent mechanism.
Leicht DT; Balan V; Zhu J; Kaplun A; Bronisz A; Rana A; Tzivion G
Biochim Biophys Acta; 2013 May; 1833(5):976-86. PubMed ID: 23360980
[TBL] [Abstract][Full Text] [Related]
11. RAF protein-serine/threonine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
[TBL] [Abstract][Full Text] [Related]
12. B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms.
Tran NH; Wu X; Frost JA
J Biol Chem; 2005 Apr; 280(16):16244-53. PubMed ID: 15710605
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism.
Chen C; Sytkowski AJ
Blood; 2004 Jul; 104(1):73-80. PubMed ID: 15026317
[TBL] [Abstract][Full Text] [Related]
14. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
15. Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation of extracellular signal-regulated kinase by epidermal growth factor.
Edin ML; Juliano RL
Mol Cell Biol; 2005 Jun; 25(11):4466-75. PubMed ID: 15899852
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Raf-1 activation and signalling by dephosphorylation.
Dhillon AS; Meikle S; Yazici Z; Eulitz M; Kolch W
EMBO J; 2002 Jan; 21(1-2):64-71. PubMed ID: 11782426
[TBL] [Abstract][Full Text] [Related]
17. Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization.
Yasuda S; Kai M; Imai S; Takeishi K; Taketomi A; Toyota M; Kanoh H; Sakane F
J Biol Chem; 2009 Oct; 284(43):29559-70. PubMed ID: 19710016
[TBL] [Abstract][Full Text] [Related]
18. Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Zebisch A; Staber PB; Delavar A; Bodner C; Hiden K; Fischereder K; Janakiraman M; Linkesch W; Auner HW; Emberger W; Windpassinger C; Schimek MG; Hoefler G; Troppmair J; Sill H
Cancer Res; 2006 Apr; 66(7):3401-8. PubMed ID: 16585161
[TBL] [Abstract][Full Text] [Related]
19. Novel C-Raf phosphorylation sites: serine 296 and 301 participate in Raf regulation.
Hekman M; Fischer A; Wennogle LP; Wang YK; Campbell SL; Rapp UR
FEBS Lett; 2005 Jan; 579(2):464-8. PubMed ID: 15642359
[TBL] [Abstract][Full Text] [Related]
20. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.
Trakul N; Menard RE; Schade GR; Qian Z; Rosner MR
J Biol Chem; 2005 Jul; 280(26):24931-40. PubMed ID: 15886202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
